Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Mueller, C. Ballard, A. Corbett, D. Aarsland (2017)
The prognosis of dementia with Lewy bodiesThe Lancet Neurology, 16
I. McKeith, B. Boeve, D. Dickson, G. Halliday, John-Paul Taylor, D. Weintraub, D. Aarsland, J. Galvin, J. Attems, C. Ballard, Ashley Bayston, T. Beach, F. Blanc, N. Bohnen, L. Bonanni, J. Bras, P. Brundin, D. Burn, A. Chen-Plotkin, J. Duda, O. El‐Agnaf, H. Feldman, T. Ferman, D. Ffytche, H. Fujishiro, D. Galasko, J. Goldman, S. Gomperts, N. Graff-Radford, L. Honig, Á. Iranzo, K. Kantarci, D. Kaufer, W. Kukull, V. Lee, J. Leverenz, S. Lewis, C. Lippa, A. Lunde, M. Masellis, E. Masliah, P. McLean, B. Mollenhauer, T. Montine, E. Moreno, E. Mori, Melissa Murray, J. O'Brien, Sotoshi Orimo, R. Postuma, S. Ramaswamy, O. Ross, D. Salmon, A. Singleton, Angela Taylor, Alan Thomas, P. Tiraboschi, J. Toledo, J. Trojanowski, D. Tsuang, Z. Walker, M. Yamada, K. Kosaka (2017)
Diagnosis and management of dementia with Lewy bodiesNeurology, 89
M. Liedorp, W. Flier, E. Hoogervorst, P. Scheltens, C. Stam (2008)
Associations between Patterns of EEG Abnormalities and Diagnosis in a Large Memory Clinic CohortDementia and Geriatric Cognitive Disorders, 27
L. Bonanni, Astrid Thomas, P. Tiraboschi, B. Perfetti, S. Varanese, M. Onofrj (2008)
EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.Brain : a journal of neurology, 131 Pt 3
Michael Connors, L. Quinto, I. McKeith, H. Brodaty, L. Allan, C. Bamford, Alan Thomas, John-Paul Taylor, J. O'Brien (2017)
Non-pharmacological interventions for Lewy body dementia: a systematic reviewPsychological Medicine, 48
C. Stinton, I. McKeith, John-Paul Taylor, L. Lafortune, E. Mioshi, E. Mak, V. Cambridge, J. Mason, Alan Thomas, J. O'Brien (2015)
Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis.The American journal of psychiatry, 172 8
Cozac (2016)
e9060649Parkinsons Dis, 2016
Bonanni (2015)
434Neurobiol Aging, 36
DFV, dominant frequency variability; LBD, Lewy body dementia
Myrto Stylianou, N. Murphy, L. Peraza, S. Graziadio, R. Cromarty, A. Killen, J. 'brien, Alan Thomas, F. LeBeau, John-Paul Taylor (2018)
Quantitative electroencephalography as a marker of cognitive fluctuations in dementia with Lewy bodies and an aid to differential diagnosisClinical Neurophysiology, 129
D. Ferreira, V. Jelic, L. Cavallin, A. Oeksengaard, J. Snaedal, P. Høgh, B. Andersen, Mala Naik, K. Engedal, E. Westman, L. Wahlund (2016)
Electroencephalography Is a Good Complement to Currently Established Dementia BiomarkersDementia and Geriatric Cognitive Disorders, 42
M. Armstrong, D. Irwin, J. Leverenz, Noheli Gamez, Angela Taylor, J. Galvin (2020)
Biomarker Use for Dementia With Lewy Body Diagnosis: Survey of US Experts.Alzheimer Disease & Associated Disorders
Yingjia Chen, L. Wilson, J. Kornak, R. Dudley, J. Merrilees, Stephen Bonasera, Christie Byrne, Kirby Lee, W. Chiong, Bruce Miller, K. Possin (2019)
The costs of dementia subtypes to California Medicare fee-for-service, 2015Alzheimer's & Dementia, 15
H. Garn, Carmina Coronel, M. Waser, G. Caravias, G. Ransmayr (2017)
Differential diagnosis between patients with probable Alzheimer’s disease, Parkinson’s disease dementia, or dementia with Lewy bodies and frontotemporal dementia, behavioral variant, using quantitative electroencephalographic featuresJournal of Neural Transmission, 124
Ferreira (2016)
80DEM, 42
J. Caviness, J. Hentz, V. Evidente, Erika Driver-Dunckley, J. Samanta, P. Mahant, D. Connor, M. Sabbagh, Holly Shill, C. Adler (2007)
Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's disease.Parkinsonism & related disorders, 13 6
C. Babiloni, C. Percio, R. Lizio, G. Noce, S. Cordone, S. Lopez, A. Soricelli, R. Ferri, M. Pascarelli, F. Nobili, D. Arnaldi, D. Aarsland, F. Orzi, C. Buttinelli, F. Giubilei, M. Onofrj, F. Stocchi, P. Stirpe, P. Fuhr, U. Gschwandtner, G. Ransmayr, G. Caravias, H. Garn, Fabiola Sorpresi, M. Pievani, G. Frisoni, F. D’Antonio, C. Lena, B. Güntekin, L. Hanoglu, E. Basar, G. Yener, D. Emek-Savaş, A. Triggiani, R. Franciotti, Maria Pandis, L. Bonanni (2017)
Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG studyNeurobiology of Aging, 55
Simela Chatzikonstantinou, Jack McKenna, E. Karantali, F. Petridis, D. Kazis, I. Mavroudis (2020)
Electroencephalogram in dementia with Lewy bodies: a systematic reviewAging Clinical and Experimental Research
J. Caviness, Rene Utianski, J. Hentz, T. Beach, B. Dugger, Holly Shill, Erika Driver-Dunckley, Marwan Sabbagh, S. Mehta, Charles Adler (2016)
Differential spectral quantitative electroencephalography patterns between control and Parkinson's disease cohortsEuropean Journal of Neurology, 23
John-Paul Taylor, I. McKeith, D. Burn, B. Boeve, D. Weintraub, C. Bamford, L. Allan, Alan Thomas, J. O'Brien (2020)
New evidence on the management of Lewy body dementiaThe Lancet Neurology, 19
L. Peraza, R. Cromarty, X. Kobeleva, M. Firbank, A. Killen, S. Graziadio, Alan Thomas, J. O'Brien, John-Paul Taylor (2018)
Electroencephalographic derived network differences in Lewy body dementia compared to Alzheimer’s disease patientsScientific Reports, 8
(2017)
Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium, 89
B. Klassen, J. Hentz, Holly Shill, Erika Driver-Dunckley, V. Evidente, M. Sabbagh, C. Adler, J. Caviness (2011)
Quantitative EEG as a predictive biomarker for Parkinson disease dementiaNeurology, 77
G. Roks, E. Korf, W. Flier, P. Scheltens, C. Stam (2007)
The use of EEG in the diagnosis of dementia with Lewy bodiesJournal of Neurology, Neurosurgery, and Psychiatry, 79
K. Engedal, J. Snaedal, P. Hoegh, V. Jelic, Birgitte Andersen, Mala Naik, L. Wahlund, A. Oeksengaard (2015)
Quantitative EEG Applying the Statistical Recognition Pattern Method: A Useful Tool in Dementia Diagnostic WorkupDementia and Geriatric Cognitive Disorders, 40
L. Bonanni, R. Franciotti, F. Nobili, M. Kramberger, John-Paul Taylor, S. García-Ptacek, N. Falasca, F. Famà, R. Cromarty, M. Onofrj, D. Aarsland (2016)
EEG Markers of Dementia with Lewy Bodies: A Multicenter Cohort Study.Journal of Alzheimer's disease : JAD, 54 4
Bonanni L, Perfetti B, Bifolchetti S, Taylor Jp, Franciotti R, Parnetti L, Thomas A, Onofrj M, L. Bonanni, B. Perfetti, S. Bifolchetti, John-Paul Taylor, R. Franciotti, L. Parnetti, Astrid Thomas, M. Onofrj
This Work Is Licensed under a Creative Commons Attribution 3.0 Unported License Quantitative Electroencephalogram Utility in Predicting Conversion of Mild Cognitive Impairment to Dementia with Lewy Bodies
(2015)
Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies, 36
V. Cozac, U. Gschwandtner, F. Hatz, M. Hardmeier, S. Rüegg, P. Fuhr (2016)
Quantitative EEG and Cognitive Decline in Parkinson's DiseaseParkinson's Disease, 2016
M. Boustani, N. Campbell, Stephanie Munger, I. Maidment, C. Fox (2008)
Impact of anticholinergics on the aging brain: a review and practical applicationAging Health, 4
Objective: To determine the minimum duration of electroencephalography (EEG) data necessary to differentiate EEG features of Lewy body dementia (LBD), that is, dementia with Lewy bodies and Parkinson disease dementia, from non-LBD patients, that is, Alzheimer disease and Parkinson disease. Methods: We performed quantitative EEG analysis for 16 LBD and 14 non-LBD patients. After artifact removal, a fast Fourier transform was performed on 90, 60, and thirty 2-second epochs to derive dominant frequency; dominant frequency variability; and dominant frequency prevalence. Results: In LBD patients, there were no significant differences in EEG features derived from 90, 60, and thirty 2-second epochs (all P>0.05). There were no significant differences in EEG features derived from 3 different groups of thirty 2-second epochs (all P>0.05). When analyzing EEG features derived from ninety 2-second epochs, we found that LBD had significantly reduced dominant frequency, reduced dominant frequency variability, and reduced dominant frequency prevalence alpha compared with the non-LBD group (all P<0.05). These same differences were observed between the LBD and non-LBD groups when analyzing thirty 2-second epochs. Conclusions: There were no differences in EEG features derived from 1 minute versus 3 minutes of EEG data, and both durations of EEG data equally differentiated LBD from non-LBD.
Alzheimer Disease & Associated Disorders – Wolters Kluwer Health
Published: Jan 22, 2023
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.